Welcome to LookChem.com Sign In|Join Free

CAS

  • or

935467-23-5

C25H45NO3Si is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

935467-23-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 935467-23-5 Structure

  • Basic information

    1. Product Name: C25H45NO3Si
    2. Synonyms: C25H45NO3Si
    3. CAS NO:935467-23-5
    4. Molecular Formula:
    5. Molecular Weight: 435.723
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 935467-23-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C25H45NO3Si(CAS DataBase Reference)
    10. NIST Chemistry Reference: C25H45NO3Si(935467-23-5)
    11. EPA Substance Registry System: C25H45NO3Si(935467-23-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 935467-23-5(Hazardous Substances Data)

935467-23-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 935467-23-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,4,6 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 935467-23:
(8*9)+(7*3)+(6*5)+(5*4)+(4*6)+(3*7)+(2*2)+(1*3)=195
195 % 10 = 5
So 935467-23-5 is a valid CAS Registry Number.

935467-23-5Downstream Products

935467-23-5Relevant articles and documents

COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS

-

, (2017/12/29)

Described herein are methods of treating a metabolic disorder in an individual in need thereof, comprising co-administering to the individual a therapeutically effective amount of an FXR modulator, and at least one second agent that is an CCR2/CCR5 antagonist, ASKl inhibitor, DPP-IV inhibitor, caspase protease inhibitor, SGLT2 inhibitor, acetyl-CoA carboxylase (ACC) inhibitor, diacyl glycerol acyltransferase-1 inhibitor, sodium -bile acid cotransporter-inhibitor, TLR-4 antagonist, PPAR alpha/delta agonist, or GLP-1 agonist, or a combination thereof.

Synthesis of a highly functionalised azepine via a new TBSOTf-mediated cyclisation of a terminal formamide

Heuser, Stefan

, p. 497 - 499 (2007/12/25)

The synthesis of a highly functionalised azepine which can be further derivatised by common chemical transformations is described herein. The present synthesis comprises high-yielding reaction steps and features a new method for the synthesis of azepines via TBSOTf-mediated cyclisation of terminal formamides. Georg Thieme Verlag Stuttgart.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 935467-23-5